Angitia Incorporated Limited is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. Focusing on areas such as bone, cartilage, and muscle, Angitia leverages its team's expertise in new drug development to address unmet medical needs, bringing cutting-edge treatments to patients.
The Director of Clinical Quality Assurance will be responsible for ensuring the quality and compliance of Angitia sponsored clinical studies related to Standard Operating Procedures, regulatory requirements (FDA, ICH), and GLP studies. This role involves team leadership, process development, audit readiness, and ensuring GxP compliance. It reports to the VP, Head of Global Clinical Operations.
Angitia Incorporated Limited is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. Focusing on areas such as bone, cartilage, and muscle, Angitia leverages its team's expertise in new drug development to address unmet medical needs, bringing cutting-edge treatments to patients.
Lyell Immunopharma